General Structure Information 4bfb BACE2 bace2 xaperone complex 2.21Å AUTH D.W.BANNER,B.GSELL,J.BENZ,J.BERTSCHINGER,D.BURGER,S.BRACK,AUTH 2 S.CUPPULERI,M.DEBULPAEP,A.GAST,D.GRABULOVSKI,M.HENNIG,AUTH 3 H.HILPERT,W.HUBER,A.KUGLSTATTER,E.KUSZNIR,T.LAEREMANS,AUTH 4 H.MATILE,C.MISCENIC,A.RUFER,D.SCHLATTER,J.STEYEART,M.STIHLE,AUTH 5 R.THOMA,M.WEBER,A.RUFTITL MAPPING THE CONFORMATIONAL SPACE ACCESSIBLE TO BACE2 USINGTITL 2 SURFACE MUTANTS AND CO-CRYSTALS WITH FAB-FRAGMENTS,TITL 3 FYNOMERS, AND XAPERONESREF ACTA CRYSTALLOGR.,SECT.D V. 69 1124 2013REFN ISSN 0907-4449PMID 23695257DOI 10.1107/S0907444913006574 Variant Set Distributions Ripley’s K Analysis Plots […]
General Structure Information 4kro EGFR nanobody/vhh domain ega1 in complex with the extracellular region of egfr 3.05Å AUTH K.R.SCHMITZ,A.BAGCHI,R.C.ROOVERS,AUTH 2 P.M.VAN BERGEN EN HENEGOUWEN,K.M.FERGUSONTITL STRUCTURAL EVALUATION OF EGFR INHIBITION MECHANISMS FORTITL 2 NANOBODIES/VHH DOMAINS.REF STRUCTURE V. 21 1214 2013REFN ISSN 0969-2126PMID 23791944DOI 10.1016/J.STR.2013.05.008 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity […]